Synthesis and evaluation of non-dimeric HCV NS5A inhibitors-Reference-Cited by-同舟云学术

Synthesis and evaluation of non-dimeric HCV NS5A inhibitors

Published:2013-04 Issue:7 Volume:23 Page:2031-2034
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Amblard Franck,Zhang Hongwang,Zhou Longhu,Shi Junxing,Bobeck Drew R.,Nettles James H.,Chavre Satish,McBrayer Tamara R.,Tharnish Philip,Whitaker Tony,Coats Steven J.,Schinazi Raymond F.

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference24 articles.

1. Hepatitis C-global prevalence (update). WHO wkly. Epidemio. rec 1999, 74, 425.

2. Treatment of hepatitis C

3. New Merck and Vertex drugs raise standard of care in hepatitis C

4. Development of novel therapies for hepatitis C

5. Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthetic approaches to potent heterocyclic inhibitors of tuberculosis: A decade review;Frontiers in Pharmacology;2022-10-31

2. Discovery of a novel unsymmetrical structural class of HCV NS5A inhibitors with low picomolar antiviral activity;Bioorganic & Medicinal Chemistry Letters;2020-03

3. Sulfur(vi) fluoride exchange as a key reaction for synthesizing biaryl sulfate core derivatives as potent hepatitis C virus NS5A inhibitors and their structure–activity relationship studies;RSC Advances;2018

4. One-pot synthesis of α-bromo- and α-azidoketones from olefins by catalytic oxidation with in situ-generated modified IBX as the key reaction;Tetrahedron;2017-10

5. New potent biaryl sulfate-based hepatitis C virus inhibitors;European Journal of Medicinal Chemistry;2017-01